IBDEI0WZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16284,1,4,0)
 ;;=4^346.51
 ;;^UTILITY(U,$J,358.3,16284,1,5,0)
 ;;=5^Migraine,Prst w/ Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,16284,2)
 ;;=^336578
 ;;^UTILITY(U,$J,358.3,16285,0)
 ;;=346.70^^92^935^77
 ;;^UTILITY(U,$J,358.3,16285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16285,1,4,0)
 ;;=4^346.70
 ;;^UTILITY(U,$J,358.3,16285,1,5,0)
 ;;=5^Migraine,Chr w/o Aura
 ;;^UTILITY(U,$J,358.3,16285,2)
 ;;=^336748
 ;;^UTILITY(U,$J,358.3,16286,0)
 ;;=780.72^^92^935^93
 ;;^UTILITY(U,$J,358.3,16286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16286,1,4,0)
 ;;=4^780.72
 ;;^UTILITY(U,$J,358.3,16286,1,5,0)
 ;;=5^Quadraplegia,Functional
 ;;^UTILITY(U,$J,358.3,16286,2)
 ;;=^336672
 ;;^UTILITY(U,$J,358.3,16287,0)
 ;;=344.00^^92^935^99
 ;;^UTILITY(U,$J,358.3,16287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16287,1,4,0)
 ;;=4^344.00
 ;;^UTILITY(U,$J,358.3,16287,1,5,0)
 ;;=5^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,16287,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,16288,0)
 ;;=344.1^^92^935^86
 ;;^UTILITY(U,$J,358.3,16288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16288,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,16288,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,16288,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,16289,0)
 ;;=907.2^^92^935^74
 ;;^UTILITY(U,$J,358.3,16289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16289,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,16289,1,5,0)
 ;;=5^Late Effect of SCI
 ;;^UTILITY(U,$J,358.3,16289,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,16290,0)
 ;;=V12.54^^92^935^72
 ;;^UTILITY(U,$J,358.3,16290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16290,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,16290,1,5,0)
 ;;=5^Hx of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,16290,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,16291,0)
 ;;=438.10^^92^935^14
 ;;^UTILITY(U,$J,358.3,16291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16291,1,4,0)
 ;;=4^438.10
 ;;^UTILITY(U,$J,358.3,16291,1,5,0)
 ;;=5^CVA w/Language (late effect)
 ;;^UTILITY(U,$J,358.3,16291,2)
 ;;=^317906
 ;;^UTILITY(U,$J,358.3,16292,0)
 ;;=438.11^^92^935^3
 ;;^UTILITY(U,$J,358.3,16292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16292,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,16292,1,5,0)
 ;;=5^CVA w/Aphasia (late effect)
 ;;^UTILITY(U,$J,358.3,16292,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,16293,0)
 ;;=438.13^^92^935^6
 ;;^UTILITY(U,$J,358.3,16293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16293,1,4,0)
 ;;=4^438.13
 ;;^UTILITY(U,$J,358.3,16293,1,5,0)
 ;;=5^CVA w/Dysarthria (late effect)
 ;;^UTILITY(U,$J,358.3,16293,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,16294,0)
 ;;=438.14^^92^935^10
 ;;^UTILITY(U,$J,358.3,16294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16294,1,4,0)
 ;;=4^438.14
 ;;^UTILITY(U,$J,358.3,16294,1,5,0)
 ;;=5^CVA w/Fluency (late effect)
 ;;^UTILITY(U,$J,358.3,16294,2)
 ;;=^338240
 ;;^UTILITY(U,$J,358.3,16295,0)
 ;;=438.30^^92^935^20
 ;;^UTILITY(U,$J,358.3,16295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16295,1,4,0)
 ;;=4^438.30
 ;;^UTILITY(U,$J,358.3,16295,1,5,0)
 ;;=5^CVA w/Monoplegia Upper Arm (late effect)
 ;;^UTILITY(U,$J,358.3,16295,2)
 ;;=^317913
 ;;^UTILITY(U,$J,358.3,16296,0)
 ;;=438.31^^92^935^16
 ;;^UTILITY(U,$J,358.3,16296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16296,1,4,0)
 ;;=4^438.31
 ;;^UTILITY(U,$J,358.3,16296,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Upper Arm
 ;;^UTILITY(U,$J,358.3,16296,2)
 ;;=^317914
 ;;^UTILITY(U,$J,358.3,16297,0)
 ;;=438.32^^92^935^19
 ;;^UTILITY(U,$J,358.3,16297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16297,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,16297,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Upper Arm
